Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
008930.KS Stock Summary
Top 10 Correlated ETFs
008930.KS
In the News
008930.KS Financial details
Company Rating
Strong Buy
Market Cap
2852.85B
Income
115.12B
Revenue
1247.91B
Book val./share
11621.38
Cash/share
495.53
Dividend
196.08
Dividend %
0.52%
Employees
402
Optionable
No
Shortable
Yes
Earnings
24 Apr 2024
P/E
24.78
Forward P/E
-
PEG
3.65
P/S
2.13
P/B
3.26
P/C
89.5
P/FCF
173.98
Quick Ratio
-
Current Ratio
0.73
Debt / Equity
0.28
LT Debt / Equity
0.01
-
-
EPS (TTM)
1.69K
EPS next Y
-
EPS next Q
-
EPS this Y
67.73%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
31%
Revenue last 5Y
8.85%
Revenue Q/Q
7.3%
EPS Q/Q
12.63%
-
-
-
-
SMA20
-2.54%
SMA50
1.93%
SMA100
31%
Inst Own
-
Inst Trans
-
ROA
9%
ROE
14%
ROC
0.14%
Gross Margin
81%
Oper. Margin
10%
Profit Margin
9%
Payout
-
Shs Outstand
67.76M
Shs Float
67.76M
-
-
-
-
Target Price
-
52W Range
29850.0-56200.0
52W High
-21.09%
52W Low
+48.58%
RSI
51
Rel Volume
3.38
Avg Volume
879.8K
Volume
2.97M
Perf Week
12.42%
Perf Month
1.49%
Perf Quarter
34.6%
Perf Half Y
37.73%
-
-
-
-
Beta
1.107
-
-
Volatility
1603.95%, 1702.49%
Prev Close
9.1%
Price
44350
Change
7.65%
008930.KS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 12.13K | 12.49K | 13.85K | 15.27K | 18.36K | |
Net income per share | 456.81 | 329.31 | 625.8 | 1.01K | 1.69K | |
Operating cash flow per share | 193.53 | 201.33 | 199.5 | 137.99 | 517.37 | |
Free cash flow per share | 164.33 | 172.9 | 167.23 | 16.2 | 388.33 | |
Cash per share | 254.26 | 218.94 | 242.35 | 314.09 | 494.13 | |
Book value per share | 9.59K | 9.6K | 10.06K | 10.58K | 11.59K | |
Tangible book value per share | 9.44K | 9.47K | 9.95K | 10.3K | 11.59K | |
Share holders equity per share | 9.59K | 9.6K | 10.06K | 10.58K | 11.59K | |
Interest debt per share | 700.68 | 774.06 | 849.45 | 3K | 3.42K | |
Market cap | 2431.97B | 5020.11B | 3646.24B | 2167.83B | 2663.87B | |
Enterprise value | 2460.64B | 5056.7B | 3686.14B | 2348.42B | 2858.42B | |
P/E ratio | 79.11 | 222.12 | 84.91 | 31.32 | 23.14 | |
Price to sales ratio | 2.98 | 5.86 | 3.84 | 2.07 | 2.13 | |
POCF ratio | 186.73 | 363.32 | 266.35 | 229.36 | 75.77 | |
PFCF ratio | 219.91 | 423.04 | 317.75 | 1.95K | 100.95 | |
P/B Ratio | 3.77 | 7.62 | 5.28 | 2.99 | 3.38 | |
PTB ratio | 3.77 | 7.62 | 5.28 | 2.99 | 3.38 | |
EV to sales | 3.01 | 5.9 | 3.88 | 2.25 | 2.29 | |
Enterprise value over EBITDA | 55.36 | 131.58 | 63.54 | 27.76 | 43.48 | |
EV to operating cash flow | 188.93 | 365.96 | 269.26 | 248.47 | 81.3 | |
EV to free cash flow | 222.51 | 426.13 | 321.22 | 2.12K | 108.32 | |
Earnings yield | 0.01 | 0 | 0.01 | 0.03 | 0.04 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0.01 | |
Debt to equity | 0.07 | 0.08 | 0.08 | 0.28 | 0.28 | |
Debt to assets | 0.05 | 0.06 | 0.06 | 0.18 | 0.18 | |
Net debt to EBITDA | 0.65 | 0.95 | 0.69 | 2.13 | 2.96 | |
Current ratio | 0.95 | 0.98 | 1.01 | 0.71 | 0.69 | |
Interest coverage | 21.94 | 19.16 | 32.8 | 18.33 | 5.42 | |
Income quality | 0.42 | 0.61 | 0.32 | 0.14 | 0.31 | |
Dividend Yield | 0.01 | 0 | 0 | 0.01 | 0.01 | |
Payout ratio | 0.4 | 0.56 | 0.3 | 0.19 | 0.12 | |
Sales general and administrative to revenue | 0.01 | 0.01 | 0.01 | 0.86 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.02 | 0.06 | |
Capex to operating cash flow | -0.15 | -0.14 | -0.16 | -0.88 | -0.25 | |
Capex to revenue | 0 | 0 | 0 | -0.01 | -0.01 | |
Capex to depreciation | -0.31 | -0.31 | -0.42 | -1.52 | -1 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 9.93K | 8.43K | 11.9K | 15.51K | 21.02K | |
ROIC | 0.05 | 0.03 | 0.07 | 0.07 | 0.04 | |
Return on tangible assets | 0.03 | 0.02 | 0.05 | 0.06 | 0.1 | |
Graham Net | -1.91K | -1.88K | -1.68K | -3.27K | -3.99K | |
Working capital | -11.11B | -4.39B | 1.56B | -102.38B | -121.3B | |
Tangible asset value | 635.28B | 649.92B | 682.71B | 705.62B | 719.37B | |
Net current asset value | -48.07B | -48.76B | -37.04B | -139.59B | -164.8B | |
Invested capital | 0.07 | 0.08 | 0.08 | 0.28 | 0.28 | |
Average receivables | 97.76B | 89.32B | 93.13B | 105.32B | 110.15B | |
Average payables | 142.23B | 127.42B | 114.25B | 91.06B | 68.7B | |
Average inventory | 101.85B | 105.53B | 108.08B | 109.1B | 108.55B | |
Days sales outstanding | 40.99 | 37.02 | 38.15 | 38.85 | 31.87 | |
Days payables outstanding | 67.46 | 61.41 | 46.69 | 29.98 | 21.39 | |
Days of inventory on hand | 51.99 | 54.59 | 47.32 | 43.38 | 37.49 | |
Receivables turnover | 8.91 | 9.86 | 9.57 | 9.4 | 11.45 | |
Payables turnover | 5.41 | 5.94 | 7.82 | 12.18 | 17.06 | |
Inventory turnover | 7.02 | 6.69 | 7.71 | 8.41 | 9.74 | |
ROE | 0.05 | 0.03 | 0.06 | 0.1 | 0.15 | |
Capex per share | -29.2 | -28.42 | -32.27 | -121.8 | -129.04 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 4.23K | 4.28K | 4.64K | 4.55K | 4.9K | |
Net income per share | 335.86 | 393 | 339 | 452.98 | 510.19 | |
Operating cash flow per share | -36.74 | 151.77 | 194.73 | 243.91 | -73.4 | |
Free cash flow per share | -82.36 | 119.88 | 169.1 | 186.13 | -86.24 | |
Cash per share | 315.64 | 361.97 | 279.5 | 427.76 | 495.53 | |
Book value per share | 10.63K | 10.96K | 11.21K | 11.58K | 11.62K | |
Tangible book value per share | 10.35K | 10.68K | 10.95K | 11.32K | 11.62K | |
Share holders equity per share | 10.63K | 10.96K | 11.21K | 11.58K | 11.62K | |
Interest debt per share | 2.99K | 2.93K | 2.89K | 2.85K | 3.31K | |
Market cap | 2157.2B | 2648.03B | 2252.67B | 2240.03B | 2656.34B | |
Enterprise value | 2337.79B | 2820.65B | 2427.97B | 2403.65B | 2850.89B | |
P/E ratio | 23.56 | 24.78 | 24.45 | 18.19 | 19.21 | |
Price to sales ratio | 7.49 | 9.09 | 7.14 | 7.24 | 8 | |
POCF ratio | -861.54 | 256.64 | 170.24 | 135.09 | -534.09 | |
PFCF ratio | -384.28 | 324.92 | 196.04 | 177.02 | -454.53 | |
P/B Ratio | 2.98 | 3.56 | 2.96 | 2.85 | 3.37 | |
PTB ratio | 2.98 | 3.56 | 2.96 | 2.85 | 3.37 | |
EV to sales | 8.11 | 9.68 | 7.7 | 7.77 | 8.59 | |
Enterprise value over EBITDA | 84.33 | 9.68 | 7.7 | 7.77 | 144.55 | |
EV to operating cash flow | -933.66 | 273.37 | 183.49 | 144.96 | -573.21 | |
EV to free cash flow | -416.44 | 346.1 | 211.29 | 189.95 | -487.82 | |
Earnings yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Free cash flow yield | 0 | 0 | 0.01 | 0.01 | 0 | |
Debt to equity | 0.28 | 0.26 | 0.25 | 0.24 | 0.28 | |
Debt to assets | 0.18 | 0.17 | 0.17 | 0.17 | 0.18 | |
Net debt to EBITDA | 6.51 | 0.59 | 0.56 | 0.53 | 9.86 | |
Current ratio | 0.71 | 0.72 | 0.7 | 0.73 | 0.69 | |
Interest coverage | 13.63 | 10.8 | 10.3 | 13.72 | 7.09 | |
Income quality | -0.11 | 0.39 | 0.57 | 0.54 | -0.14 | |
Dividend Yield | 0 | 0 | 0.01 | 0 | 0 | |
Payout ratio | 0 | 0 | 0.58 | 0 | 0 | |
Sales general and administrative to revenue | 3.08 | 0.96 | 0.95 | 0.96 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.02 | 0.02 | 0.02 | 0.02 | 0.06 | |
Capex to operating cash flow | 1.24 | -0.21 | -0.13 | -0.24 | 0.18 | |
Capex to revenue | -0.01 | -0.01 | -0.01 | -0.01 | 0 | |
Capex to depreciation | -1.55 | -0.93 | -0.73 | -1.62 | -0.54 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 8.96K | 9.84K | 9.25K | 10.86K | 11.55K | |
ROIC | 0.03 | 0.03 | 0.03 | 0.03 | 0.01 | |
Return on tangible assets | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 | |
Graham Net | -3.28K | -3.31K | -2.96K | -2.91K | -4K | |
Working capital | -102.38B | -100.66B | -91.5B | -83.64B | -121.3B | |
Tangible asset value | 705.62B | 726.17B | 743.82B | 769.26B | 719.37B | |
Net current asset value | -139.59B | -139.88B | -130.61B | -123.61B | -164.8B | |
Invested capital | 0.28 | 0.26 | 0.25 | 0.24 | 0.28 | |
Average receivables | 96.02B | 114.77B | 114.87B | 111.34B | 110.06B | |
Average payables | 78.97B | 71.26B | 43.35B | 28.04B | 47.09B | |
Average inventory | 105.71B | 111.59B | 98.09B | 87.02B | 96.83B | |
Days sales outstanding | 34.78 | 36.52 | 31.83 | 32.34 | 29.55 | |
Days payables outstanding | 27.37 | 25.43 | 7.55 | 12.07 | 20.12 | |
Days of inventory on hand | 39.6 | 43.42 | 29.61 | 31.21 | 35.26 | |
Receivables turnover | 2.59 | 2.46 | 2.83 | 2.78 | 3.05 | |
Payables turnover | 3.29 | 3.54 | 11.92 | 7.46 | 4.47 | |
Inventory turnover | 2.27 | 2.07 | 3.04 | 2.88 | 2.55 | |
ROE | 0.03 | 0.04 | 0.03 | 0.04 | 0.04 | |
Capex per share | -45.63 | -31.89 | -25.62 | -57.77 | -12.85 |
008930.KS Frequently Asked Questions
What is Hanmi Science Co., Ltd. stock symbol ?
Hanmi Science Co., Ltd. is a KR stock and trading under the symbol 008930.KS
What is Hanmi Science Co., Ltd. stock quote today ?
Hanmi Science Co., Ltd. stock price is $44350 today.
Is Hanmi Science Co., Ltd. stock public?
Yes, Hanmi Science Co., Ltd. is a publicly traded company.